1. Home
  2. DTSS vs AIDX Comparison

DTSS vs AIDX Comparison

Compare DTSS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.90

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.47

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
AIDX
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
6.7M
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
DTSS
AIDX
Price
$0.90
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7M
63.4K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.48
EPS
N/A
N/A
Revenue
N/A
$2,045,133.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.71
52 Week Low
$0.53
$0.40
52 Week High
$2.50
$14.09

Technical Indicators

Market Signals
Indicator
DTSS
AIDX
Relative Strength Index (RSI) 59.62 38.79
Support Level $0.73 $0.40
Resistance Level $1.19 $0.49
Average True Range (ATR) 0.16 0.05
MACD 0.04 -0.01
Stochastic Oscillator 23.30 8.64

Price Performance

Historical Comparison
DTSS
AIDX

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: